Announcement PDF BPH Global ASX Announcement | 5 Feb 2026 1 ASX RELEASE 5 February 2026 BPH GLOBAL SECURES STRATEGIC INVESTMENT FOLLOWING STRONG SALES MOMENTUM $1M Strategic investment accelerates the next phase of rapid growth for BP8’s fast- growing Indonesian seaweed platform, opening pathways to higher-margin revenue streams. • $1.0M STRATEGIC PLACEMENT COMPLETED AT MARKET – BPH Global has received firm commitments for a $1.0 million strategic placement at $0.002 per share, completed at market price with no discount. The placement introduces new, long-term shareholders aligned with the Company’s growth strategy and strengthens the register at a key commercial point. • RECORD AND SECOND HIGHEST MONTHLY SALES RESULTS – BP8 delivered its highest monthly sales performance to date in month 6 and achieved its second highest monthly result in month 8 since commencing Indonesian seaweed trading operations in May 2025, evidencing accelerating commercial momentum, increasing counterparty demand and growing throughput across the Company’s Indonesian trading platform • IMMEDIATE SCALE-UP ENABLED – $600,000 of the proceeds from the placement are proposed to be deployed to increase trading volumes, expand export activity and lift operational throughput across BP8’s established, revenue-generating Indonesian seaweed platform. • EXECUTION RISK MATERIALLY DE-RISKED - BP8 operates from a fully commissioned Makassar warehouse and holds a valid Indonesian Government seaweed export licence, providing the infrastructure and regulatory approvals required to scale operations immediately. • CLEAR PATHWAY TO HIGH-MARTIN REVENUE - The strategic investment enhances BP8’s capacity to increase independently executed sales and selectively progress downstream initiatives, supporting a transition toward structurally higher-margin revenue streams over time. • BALANCE SHEET STRENGHTHEND FOR DISCIPLINED GROWTH - The placement positions the Company to sustain current commercial momentum while maintaining a measured progression of its longer-term biotechnology and functional nutrition opportunities. ASX RELEASE. BPH Global ASX Announcement | 5 Feb 2026 2 BPH Global Limited (ASX: BP8) (“BP8”, or the “Company) is pleased to announce that it has received firm commitments to raise $1.0 million (before costs) through a strategic placement of fully paid ordinary shares in the Company (the “Placement”). The Placement strengthens the Company’s balance sheet at a key stage in the commercial development of BP8’s Indonesian seaweed platform and introduces new long-term shareholders aligned with the Company’s growth strategy. Placement Details The Company has received binding commitments for the issue of 500,000,000 new fully paid ordinary shares at an issue price of $0.002 per share, raising $1.0 million (before costs). The Placement includes one (1) free attaching option for every two (2) Placement Shares, exercisable at $0.004 with a three (3) year expiry from the date of issue, subject to shareholder approval to be sought at a general meeting in April. The Placement Shares will be issued to sophisticated and professional investors pursuant to a placement authority approved by shareholders at the Company’s last AGM, and will rank equally with existing shares on issue. The Company expects settlement and allotment of the Placement Shares to occur in accordance with the ASX Listing Rules. Proceeds from the placement are expected to be applied approximately as follows: • Indonesian-based seaweed operations: $600.000 • Research and development initiatives: $200,000 • Working capital: $140,000 • Costs of the Offer: $60,000 The Company intends to convene an extraordinary general meeting, currently anticipated in April 2026, to seek approval for the issue of the Placement Options to investors and options to brokers who assisted with the Placement. Operational Readiness and Execution De-Risking BP8 operates from a fully commissioned warehouse facility in Makassar, Indonesia, and holds a valid Indonesian Government seaweed export licence, providing the infrastructure and regulatory approvals required to scale operations immediately. This operating platform materially reduces execution risk and enables BP8 to respond efficiently to increasing demand while maintaining logistics reliability, quality control and counterparty confidence. Scale-Up and Margin Expansion Strategy With funding secured, BP8 will prioritise scaling its core trading operations through expanded procurement, increased export throughout and continued customer engagement, with growth executed in a disciplined manner and working capital deployment closely aligned to realised demand and operational capacity. In parallel, the Company will continue to evaluate opportunities to enhance margins by increasing the proportion of independently executed sales and selectively progressing downstream initiatives, supporting a progressive transition toward structurally higher- margin revenue streams over time. ASX RELEASE. BPH Global ASX Announcement | 5 Feb 2026 3 Outlook With the Placement completed, BPH Global enters the next phase of 2026 with established operating infrastructure, secured regulatory approvals and a strengthened balance sheet, providing a solid foundation to support continued execution and scale-up across its Indonesian seaweed platform. The Company is now positioned to deploy capital in a measured manner, aligned with operational capacity and demonstrated market demand. Looking ahead, BPH Global remains focused on sustaining commercial growth while maintaining capital discipline as it progresses its broader strategy. Alongside core trading activities, the Company will continue to advance its longer-term biotechnology and functional nutrition initiatives in a staged and risk-managed way, preserving optionality and supporting the creation of sustainable, long-term shareholder value. BPH Global Limited, Non-Executive Chairman, Paul Stephenson, commented: “We are very pleased with the strong demand for this Placement. This strategic investment follows BP8’s record month 6 trading performance and a strong month 8 trading rebound and represents an important milestone in the Company’s transition from platform establishment to scaled commercial execution. The result reflects growing counterparty demand and provides further validation of the operating model BP8 has built in Indonesia since commencing trading in May 2025.” “With fully commissioned infrastructure in place, the required regulatory approvals secured and a strengthened balance sheet, BP8 is well positioned to increase volumes across its core trading platform while selectively progressing initiatives aimed at improving margins and supporting long-term value creation over time.” Sanlam Private Wealth Acted as Lead Manager and Adviser to the Offer. The Company will remunerate the brokers who assisted in raising the funds by way of: • A capital raising fee of up to 6% (plus GST); and • The issue of an aggregate 100,000,000 options, on the same terms as the Placement • Sanlam will be issued 50,000,000 options in lieu of Advisory and Management fees accrued to date on the same terms as the Placement. ENDS This release has been approved by the Board of BPH Global Limited. For further information, please visit our website at www.bphglobal.com or contact the Company Secretary on 03 9088 2049. BPH GLOBAL LTD ACN 009 104 330 Suite 303, Level 3 365 Little Collins Street Melbourne VIC 3000